Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...") |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 17: | Line 17: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
+ | |CHAPTER 2 (TUMOURS OF THE KIDNEY) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Metanephric_adenoma|Metanephric adenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Nephrogenic_rests_|Nephrogenic rests]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Nephroblastoma|Nephroblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 3 (TUMOURS OF THE URINARY TRACT) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Urothelial_papilloma|Urothelial papilloma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Villous_adenoma|Villous adenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Urachal_carcinoma|Urachal carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 27: | Line 684: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 36: | Line 695: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 4 (TUMOURS OF THE PROSTATE) |
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 54: | Line 726: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 63: | Line 737: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 72: | Line 748: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 81: | Line 759: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 90: | Line 770: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 99: | Line 781: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 108: | Line 792: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 117: | Line 803: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 126: | Line 814: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 135: | Line 825: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 144: | Line 836: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) |
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 162: | Line 867: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 171: | Line 878: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 180: | Line 889: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 189: | Line 900: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 2 (TUMOURS OF THE TESTIS) |
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 207: | Line 931: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 216: | Line 942: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Gonadoblastoma| Gonadoblastoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 225: | Line 953: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Seminoma| Seminoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 234: | Line 964: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 243: | Line 975: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 252: | Line 986: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Choriocarcinoma| Choriocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 261: | Line 997: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 270: | Line 1,008: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 279: | Line 1,019: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 288: | Line 1,030: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 297: | Line 1,041: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 306: | Line 1,052: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 315: | Line 1,063: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 324: | Line 1,074: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 333: | Line 1,085: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 342: | Line 1,096: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 351: | Line 1,107: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 360: | Line 1,118: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 369: | Line 1,129: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 378: | Line 1,140: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 387: | Line 1,151: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 396: | Line 1,162: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 405: | Line 1,173: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 414: | Line 1,184: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 423: | Line 1,195: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 432: | Line 1,206: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 441: | Line 1,217: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 450: | Line 1,228: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 459: | Line 1,239: | ||
| | | | ||
|- | |- | ||
− | | | | + | |CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) |
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Serous_cystadenoma| Serous cystadenoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 477: | Line 1,270: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 486: | Line 1,281: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 495: | Line 1,292: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 504: | Line 1,303: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 513: | Line 1,314: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 522: | Line 1,325: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Endometrioid_tumours| Endometrioid tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 531: | Line 1,336: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 540: | Line 1,347: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Brenner_tumour| Brenner tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 549: | Line 1,358: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 558: | Line 1,369: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 567: | Line 1,380: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 576: | Line 1,391: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 585: | Line 1,402: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Mesothelioma| Mesothelioma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 594: | Line 1,413: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 603: | Line 1,424: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 612: | Line 1,435: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 621: | Line 1,446: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 630: | Line 1,457: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 639: | Line 1,468: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) |
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 657: | Line 1,499: | ||
| | | | ||
|- | |- | ||
− | | ||Disease|| | + | |[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 666: | Line 1,640: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 675: | Line 1,651: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Paraganglioma|Paraganglioma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 684: | Line 1,662: | ||
| | | | ||
|- | |- | ||
− | | || | + | |CHAPTER 10 (MESENCHYMAL TUMOURS) |
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 702: | Line 1,693: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 711: | Line 1,704: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 720: | Line 1,715: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Haemangioma|Haemangioma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 729: | Line 1,726: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[MALE5:Angiosarcoma|Angiosarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 738: | Line 1,737: | ||
| | | | ||
|- | |- | ||
+ | |[[MALE5:Glomus_tumour|Glomus tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
| | | | ||
+ | |- | ||
+ | |[[MALE5:Myointimoma|Myointimoma]] | ||
|Disease | |Disease | ||
| | | | ||
Line 748: | Line 1,758: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |[[MALE5:Myopericytoma|Myopericytoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Leiomyoma|Leiomyoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Leiomyosarcoma|Leiomyosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Synovial_sarcoma|Synovial sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Plasmacytoma|Plasmacytoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 12 (MELANOCYTIC LESIONS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Mucosal_melanoma|Mucosal melanoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Carney_complex|Carney complex]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|} | |} |
Revision as of 16:42, 15 July 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.